We are live on
!
Find out more
Algert Global Portfolio holdings
AUM
$8.43B
Turnover
35.21%
1-Year Est. Return
80.94%
This Fund
S&P 500
This Quarter
Est. Return
+7.51%
1 Year Est. Return
+80.94%
3 Year Est. Return
+194.06%
5 Year Est. Return
+268.69%
10 Year Est. Return
+1,949.39%
AUM
$6.65B
AUM Growth
+$233M
(+3.6%)
Cap. Flow
+$197M
Cap. Flow
% of AUM
2.96%
Top 10 Holdings %
Top 10 Hldgs %
6.29%
Holding
1,376
New
256
Increased
454
Reduced
375
Closed
242
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dynatrace
DT
|
+$26M |
| 2 |
Lear
LEA
|
+$24.8M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$21.5M |
| 4 |
DocuSign
DOCU
|
+$20.9M |
| 5 |
Graphic Packaging
GPK
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TechnipFMC
FTI
|
+$33.5M |
| 2 |
Synovus
SNV
|
+$30.2M |
| 3 |
BWX Technologies
BWXT
|
+$27M |
| 4 |
SM Energy
SM
|
+$22.8M |
| 5 |
REV Group
REVG
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.8% |
| 2 | Technology | 15.91% |
| 3 | Financials | 13.6% |
| 4 | Healthcare | 13.04% |
| 5 | Consumer Discretionary | 12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Ovintiv
OVV
$18.6B
| $7.21M | 0.11% |
121,520
-295,298
| -71% | -$14.2M |
2025 Q2
3 quarters
|
|
327
Tyra Biosciences
TYRA
$1.29B
| $7.2M | 0.11% |
188,010
+141,140
| +301% | +$4.57M |
2025 Q4
1 quarter
|
|
328
Kontoor Brands
KTB
$4.06B
| $7.19M | 0.11% |
102,269
+88,099
| +622% | +$5.77M |
2024 Q4
5 quarters
|
|
329
QXO Inc
QXO
$11.6B
| $7.12M | 0.11% |
366,520
+51,310
| +16% | +$1.17M |
2025 Q2
3 quarters
|
|
330
Colgate-Palmolive
CL
$74.8B
| $7.11M | 0.11% |
83,440
+74,552
| +839% | +$6.64M |
2025 Q3
2 quarters
|
|
331
Monster Beverage
MNST
$90.6B
| $7.1M | 0.11% |
195,892
-17,684
| -8% | -$697K |
2025 Q1
4 quarters
|
|
332
Mineralys Therapeutics
MLYS
$1.88B
| $7.05M | 0.11% |
260,264
+212,764
| +448% | +$6.24M |
2025 Q3
2 quarters
|
|
333
Tesla
TSLA
$1.45T
| $7.04M | 0.11% |
18,942
-1,157
| -6% | -$477K |
2024 Q3
6 quarters
|
|
334
SouthState Bank Corp
SSB
$9.98B
| $7.01M | 0.11% |
75,780
+60,780
| +405% | +$5.96M |
2025 Q3
2 quarters
|
|
335
Viasat
VSAT
$8.27B
| $7.01M | 0.11% |
152,985
+35,707
| +30% | +$1.61M |
2025 Q1
4 quarters
|
|
336
Las Vegas Sands
LVS
$24.8B
| $7M | 0.11% |
129,884
+14,033
| +12% | +$799K |
2025 Q3
2 quarters
|
|
337
Dollar General
DG
$29.7B
| $6.99M | 0.11% |
58,905
+16,101
| +38% | +$2.3M |
2025 Q4
1 quarter
|
|
338
Primerica
PRI
$8.75B
| $6.94M | 0.1% |
27,721
| – | – |
2022 Q3
14 quarters
|
|
339
Dole
DOLE
$1.27B
| $6.92M | 0.1% |
484,526
-144,921
| -23% | -$2.2M |
2024 Q3
6 quarters
|
|
340
Urban Edge Properties
UE
$2.45B
| $6.91M | 0.1% |
346,095
-135,085
| -28% | -$2.72M |
2024 Q2
7 quarters
|
|
341
BILL Holdings
BILL
$4.04B
| $6.9M | 0.1% |
+180,240
| New | +$8.06M |
2026 Q1
0 quarters
|
|
342
Evercore
EVR
$9.93B
| $6.88M | 0.1% |
23,049
+12,950
| +128% | +$4.24M |
2023 Q4
9 quarters
|
|
343
Celldex Therapeutics
CLDX
$2.24B
| $6.82M | 0.1% |
215,159
+116,312
| +118% | +$3.17M |
2021 Q3
18 quarters
|
|
344
NovoCure
NVCR
$1.66B
| $6.82M | 0.1% |
625,797
-253,201
| -29% | -$3.16M |
2024 Q4
5 quarters
|
|
345
The Mosaic Company
MOS
$6.02B
| $6.75M | 0.1% |
264,586
-122,709
| -32% | -$3.37M |
2025 Q1
4 quarters
|
|
346
Invesco
IVZ
$12.9B
| $6.72M | 0.1% |
276,597
-171,210
| -38% | -$4.48M |
2024 Q2
7 quarters
|
|
347
Xeris Biopharma Holdings
XERS
$1.82B
| $6.71M | 0.1% |
1,156,958
+438,114
| +61% | +$2.9M |
2025 Q3
2 quarters
|
|
348
Royalty Pharma
RPRX
$26.7B
| $6.63M | 0.1% |
138,260
+28,930
| +26% | +$1.27M |
2025 Q4
1 quarter
|
|
349
Elastic
ESTC
$10B
| $6.62M | 0.1% |
132,404
+6,028
| +5% | +$370K |
2021 Q3
18 quarters
|
|
350
Citigroup
C
$213B
| $6.6M | 0.1% |
58,240
+1,313
| +2% | +$150K |
2024 Q3
6 quarters
|
|
Similar funds
AIM
Algert Global's Q1 2026 Portfolio in Review
As of Q1 2026, Algert Global held 1,376 positions worth $6.65B, up 3.6% from $6.41B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Algert Global's Q1 2026 filing shows 256 new, 454 increased, 375 reduced and 242 closed positions. Its largest new stake was Lear: 198,607 shares worth $24M. The largest sale was TechnipFMC, an estimated $33.5M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Algert Global's largest Q1 2026 buy was Lear: 198,607 shares worth $24M.
- Algert Global added most to Dynatrace in Q1 2026, an estimated $26M increase.
- Algert Global's biggest Q1 2026 reduction was TechnipFMC, cutting an estimated $33.5M.
- Algert Global fully exited Synovus in Q1 2026, selling an estimated $30.2M.
- Algert Global's ten largest holdings make up 6.3% of its $6.65B portfolio in Q1 2026.
- Algert Global opened 256 new positions and closed 242 in Q1 2026.
- Algert Global's portfolio value rose 3.6% quarter-over-quarter to $6.65B.
Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.